For the first time in nearly 15 years, the U.S. Patent and Trademark Office (USPTO) has issued "Updated Guidance for Making a Proper Determination of Obviousness" under the U.S.
For the first time in nearly 15 years, the U.S. Patent and Trademark Office (USPTO) has issued “Updated Guidance for Making a Proper Determination of Obviousness” under the U.S. Supreme.
One of the main risks that a company faces after a data breach is a potential lawsuit. Plaintiffs often will allege creative statutory and common law theories of harm after they learn that their personal information.
(December 27, 2023) Natera Inc. succeeded in obtaining a preliminary injunction against NeoGenomics Laboratories, Inc.’s medical assay test. Natera’s ongoing federal lawsuit alleges.
The United States Court of Appeals for the Federal Circuit recently delivered a precedential opinion in Baxalta v. Genentech, affirming the invalidity of patent claims directed to a genus of antibodies.